The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 11,409,898 | 1,021,477 | SH | SOLE | 1,021,477 | 0 | 0 | ||
ACELYRIN INC | COM | 00445A100 | 2,662,653 | 356,924 | SH | SOLE | 356,924 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 712,980 | 222,112 | SH | SOLE | 222,112 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 1,287,687 | 16,179 | SH | SOLE | 16,179 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 8,329,381 | 206,326 | SH | SOLE | 206,326 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 14,828,074 | 177,603 | SH | SOLE | 177,603 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 5,542,540 | 379,626 | SH | SOLE | 379,626 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 3,170,858 | 847,823 | SH | SOLE | 847,823 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 440,148 | 45,801 | SH | SOLE | 45,801 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 8,941,076 | 251,295 | SH | SOLE | 251,295 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 834,113 | 79,213 | SH | SOLE | 79,213 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 17,732,835 | 598,072 | SH | SOLE | 598,072 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 8,577,331 | 203,592 | SH | SOLE | 203,592 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 528,001 | 123,944 | SH | SOLE | 123,944 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 9,592,775 | 189,618 | SH | SOLE | 189,618 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 2,968,044 | 74,649 | SH | SOLE | 74,649 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 1,995,629 | 16,086 | SH | SOLE | 16,086 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 3,403,552 | 54,896 | SH | SOLE | 54,896 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 5,026,766 | 462,444 | SH | SOLE | 462,444 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 3,866,629 | 29,346 | SH | SOLE | 29,346 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 2,292,715 | 347,381 | SH | SOLE | 347,381 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,693,749 | 379,143 | SH | SOLE | 379,143 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 1,961,918 | 71,760 | SH | SOLE | 71,760 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 3,662,788 | 326,161 | SH | SOLE | 326,161 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 3,827,050 | 814,266 | SH | SOLE | 814,266 | 0 | 0 | ||
SO YOUNG INTERNATIONAL INC | SPONSORED ADS | 83356Q108 | 1,003,034 | 796,059 | SH | SOLE | 796,059 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 348,125 | 118,814 | SH | SOLE | 118,814 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 3,831,450 | 255,430 | SH | SOLE | 255,430 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 2,465,915 | 124,040 | SH | SOLE | 124,040 | 0 | 0 | ||
YS BIOPHARMA CO LTD | ORDINARY SHARES | G9845F109 | 165,661 | 307,920 | SH | SOLE | 307,920 | 0 | 0 |